CANDACE HACK: Open Payments
NPI 1407445059 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 96 payments from 12 companies in 2025. Trend: 2023 $609 · 2024 $408 · 2025 $1,527
Food & beverage: $1,527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $219 |
| Vanda Pharmaceuticals Inc. | 6 | $213 |
| Alkermes, Inc. | 6 | $202 |
| Otsuka America Pharmaceutical, Inc. | 9 | $180 |
| Supernus Pharmaceuticals, Inc. | 17 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $142 |
| E.R. Squibb & Sons, L.L.C. | 9 | $135 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| Lundbeck LLC | 4 | $70 |
| Corium, LLC | 5 | $67 |
Products named: VRAYLAR, LYBALVI, Qelbree, FANAPT, CAPLYTA, COBENFY, REXULTI, ABILIFY MAINTENA.
Industry payments across KY — which companies pay providers there.
